Martin Rabel obtained his pharmaceutical license, postgraduate diploma, and PhD from the Friedrich-Schiller-University Jena. For his diploma he worked on Bacterial Nanocellulose (BNC) nanoparticles for gene delivery applications. His Ph.D. research focused on the development of animal-free simulation models for the development of complex diagnostic nanoparticles (IONP). After working in local pharmacies and as Drug Safety Officer for Mibe Arnzeimittel GmbH he joined Precision NanoSystems ULC in 2019 currently working as Senior Field Application Scientist (FAS) supporting clients in Central Europe, Middle East, and Africa (EMEA). He is specialized in the development of novel nanomedicines using PNI´s microfluidic NanoAssemblr platform and proprietary LNP-based gene delivery reagents. His expertise spans formulation development, optimization as well as scale-up and GMP manufacturing including the necessary analytical and downstream processing methods.